Drug intelligence / Profile preview

S4S

Development stage: Discontinued
Lead developer: Dr. Pyke
Administration: Oral

Overview

S4S, also known as Dr. Pyke's Supplement for Stream, is a proprietary dietary supplement combining Panax ginseng extract, L-citrulline, beta-sitosterol, and vitamin D3. It was investigated in a clinical trial for its potential effects on prostatism and erectile dysfunction, aiming to assess its impact on lower urinary tract symptoms and sexual function, as well as its tolerability.

Brand names: Dr. Pyke's Supplement for Stream

Targets

VDR (Vitamin D receptor)NOS1 (nNOS)

Beyond the preview

Go deeper on S4S.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on S4S.

Explore the full profile